- Home
- OPTU vs EVMN Comparison
OPTU vs EVMN Comparison
Compare OPTU & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPTU | EVMN |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 567.7M | 474.7M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | OPTU | EVMN |
|---|---|---|
| Price | $0.97 | $10.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $1.75 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 1.9M | 575.4K |
| Earning Date | 05-07-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.23 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,590,467,000.00 | $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $0.58 | $10.30 |
| 52 Week High | $2.14 | $33.20 |
Technical Indicators
Market Signals| Indicator | OPTU | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 52.66 | 32.51 |
| Support Level | $0.72 | N/A |
| Resistance Level | $1.11 | $15.06 |
| Average True Range (ATR) | 0.09 | 0.72 |
| MACD | 0.00 | -0.29 |
| Stochastic Oscillator | 53.12 | 3.14 |
Price Performance
Historical ComparisonAbout OPTU Optimum Communications Inc. Class A common stock
Optimum's assets were brought together when Altice Europe acquired US cable companies Suddenlink in 2015 and Cablevision in 2016. The Suddenlink business, which management calls the "West," provides television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. The Cablevision portion, dubbed the "East," provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Optimum, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.